Literature DB >> 8052974

A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

J E Sadler1.   

Abstract

A simplified phenotypic classification of von Willebrand disease is proposed that is based on differences in pathophysiology. Quantitative defects are divided into partial deficiency (type 1) and severe deficiency (type 3). Qualitative defects (type 2) are divided into four subcategories. Type 2A refers to variants with decreased platelet-dependent function associated with the loss of high-molecular weight VWF multimers. Type 2B refers to variants with increased affinity for platelet glycoprotein Ib. Type 2M refers to qualitatively abnormal variants with decreased platelet-dependent function not associated with the loss of high-molecular weight multimers. Type 2N refers to variants with decreased affinity for factor VIII. When recognized, mixed phenotypes caused by compound heterozygosity are indicated by separate classification of each allele. Standard amino acid and nucleotide numbering schemes are recommended for the description of mutations.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8052974

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  44 in total

Review 1.  Genetic abnormalities of Bernard-Soulier syndrome.

Authors:  Shinji Kunishima; Tadashi Kamiya; Hidehiko Saito
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Integration of molecular and clinical data of 40 unrelated von Willebrand Disease families in a Spanish locus-specific mutation database: first release including 58 mutations.

Authors:  Irene Corrales; Lorena Ramírez; Júlia Ayats; Carme Altisent; Rafael Parra; Francisco Vidal
Journal:  Haematologica       Date:  2010-08-26       Impact factor: 9.941

3.  General surgery in patients with a bleeding diathesis: how we do it.

Authors:  Kamal R Aryal; D Wiseman; Ajith K Siriwardena; Paula H B Bolton-Maggs; Charles R M Hay; James Hill
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

Review 4.  Neonatal coagulation problems.

Authors:  E A Chalmers
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-11       Impact factor: 5.747

5.  High-throughput molecular diagnosis of von Willebrand disease by next generation sequencing methods.

Authors:  Irene Corrales; Susana Catarino; Júlia Ayats; David Arteta; Carmen Altisent; Rafael Parra; Francisco Vidal
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

6.  An unexpected transmission of von Willebrand disease type 3: the first case of maternal uniparental disomy 12.

Authors:  Pierre Boisseau; Mathilde Giraud; Catherine Ternisien; Agnès Veyradier; Edith Fressinaud; Armelle Lefrancois; Stéphane Bezieau; Marc Fouassier
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

Review 7.  Laboratory testing for von Willebrand disease: toward a mechanism-based classification.

Authors:  Richard Torres; Yuri Fedoriw
Journal:  Clin Lab Med       Date:  2009-06       Impact factor: 1.935

Review 8.  Etiology and management of coagulation abnormalities in the pain management patient.

Authors:  E Cobos; J C Cruz; M Day
Journal:  Curr Rev Pain       Date:  2000

Review 9.  [Von Willebrand disease : diagnosis and management].

Authors:  C Antony; R Rossaint; G Schaelte
Journal:  Internist (Berl)       Date:  2010-09       Impact factor: 0.743

10.  Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations.

Authors:  Jeffrey J Sutherland; Lee A O'Brien; David Lillicrap; Donald F Weaver
Journal:  J Mol Model       Date:  2004-08-03       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.